Meal timing may change how this drug works
NCT ID NCT07193576
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 trial studied how taking flonoltinib maleate tablets with or without food changes the drug's levels in the blood. Twenty-four healthy adults aged 18 to 45 took a single 100 mg dose under both fed and fasting conditions. The goal was to understand food's impact on drug absorption, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- flonoltinib maleate
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEATHLY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chengdu Xinhua Hospital
Chengdu, Sichuan, 610000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.